We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Cambridge Nutraceuticals develop and sell healthcare supplements that are proven to provide health benefits. Their products ar ecurrently on shelves in a number of the large high street retailers such as Holland & Barrett and Boots.
days to go: Expired investment: £1,077,710
Customers can have the chance to win highly desirable properties ranging from £350,000 to £650,000. After purchasing a £5 ticket and answering one multiple-choice question correctly, customers will be entered into a draw to win a property. Raffle House also donate 5% of their ticket sales revenue to a homelessness charity chosen by their customers.
days to go: Expired investment: £269,419
Regit is a cars digital garage. They make buying, selling and maintaining your car easier, by bringing all the best deals and providers together.  The platform performs many functions using the vehicle registration number, it creates digital garage with all their key dates in it so they stay safe and legal.  From there they create a market place for consumers to buy, sell or maintain their car. The platform currently has 1.4 million users and are looking for funding to expand the team, improve the consumer product and grow the registered user base to over 6million users. .
days to go: Expired investment: £796,040
Morpher have created a new concept in helmet convenience, the helmet folds flat so that it can easily be transported. The helmet is just as safe as regular rigid helmets and has passed all the relevant safety criteria for most of the world. Morpher not only want a safer world but want a greener world and have ensured most of the helmets components are recyclable.   
days to go: Expired investment: £1,061,666
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
Plumen are aiming to persuade people to use energy efficient lighting by creating beautiful bulbs. To date, Plumen have expanded the business and funded R&D using their own sales. However now they are looking to expand. Plumen are seeking investment to: launch new product ranges, support and grow sales into new markets and develop smart lighting for launch in 2017. 
days to go: Expired investment: £695,680
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph